Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Insider trading at ADVANCED MEDICAL OPTICS INC (EYE) refers to stock transactions executed by corporate insiders—officers, directors, and shareholders owning more than 10% of the company. Over the past 90 days, 74 insiders have filed 989 transactions totaling $6.1B in trading activity. The most active insider is Laboratories Abbott (Executive), contributing $2.2B across 2 transactions.
ADVANCED MEDICAL OPTICS INC insiders are currently net sellers of EYE stock, showing bearish sentiment over the past 90 days. Total sales of $3.8B outpace purchases of $2.3B, creating a net outflow of $1.5B.
ADVANCED MEDICAL OPTICS INC has 74 active insiders who have filed SEC Form 4 transactions in the past 90 days. Laboratories Abbott (Executive) leads with 2 transactions totaling $2.2B. North America Fund XI L.p. Kkr (Executive) follows with 2 transactions worth $842.3M. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.
The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. ADVANCED MEDICAL OPTICS INC's current score of 38/100 indicates bearish insider sentiment. Scores below 40 indicate selling pressure exceeds buying. Insider selling often reflects diversification needs, tax optimization, or estate planning.
The most recent insider transaction occurred on Oct 3, 2025, when Patel Priti V (Executive) disposed of 1,502 shares at $0.00 per share for $0. This appears to be a discretionary trade.
Based on SEC Form 4 filings from the past 90 days, EYE insider trading sentiment is currently bearish with an Alignment Score of 38/100. The negative net flow of $1.5B shows more selling than buying. However, 0% of recent transactions are 10b5-1 scheduled trades.
SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like ADVANCED MEDICAL OPTICS INC. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At EYE, we track all Form 4 filings—currently showing 989 transactions from 74 insiders over 90 days.
A 10b5-1 plan allows ADVANCED MEDICAL OPTICS INC executives to pre-schedule stock sales when they don't possess material non-public information. At EYE, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at EYE appears discretionary, making insider signals more meaningful.
You can monitor ADVANCED MEDICAL OPTICS INC (EYE) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 74 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.
Insider trading at ADVANCED MEDICAL OPTICS INC (EYE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of shares. These individuals must report trades to the SEC within two business days. Currently, 74 insiders are actively trading EYE stock, having executed 989 transactions in the past 90 days. The most active insider is Laboratories Abbott (Executive), with 2 transactions totaling $2.2B.
Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. ADVANCED MEDICAL OPTICS INC's current score of 38/100 indicates moderately bearish sentiment with selling outpacing buying. This is calculated from $2.3B in purchases versus $3.8B in sales over 90 days, resulting in a net flow of -$1.5B.
SEC Form 4 filings are mandatory reports that ADVANCED MEDICAL OPTICS INC insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At EYE, the most common type is "M" with 21 occurrences. The most recent Form 4 was filed on Oct 3, 2025 by Patel Priti V.
Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At ADVANCED MEDICAL OPTICS INC, approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at EYE represents discretionary decisions with more informational value.
Set alerts for ADVANCED MEDICAL OPTICS INC and 40,000+ other insiders.